These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 8411552)

  • 21. 3-D reconstruction of anterior mantle-field techniques in Hodgkin's disease survivors: doses to cardiac structures.
    Vordermark D; Seufert I; Schwab F; Kölbl O; Kung M; Angermann C; Flentje M
    Radiat Oncol; 2006 Apr; 1():10. PubMed ID: 16722610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Myocardial infarction after mediastinal radiotherapy of Hodgkin's disease].
    Tres A; Fuertes MA; Callén L; Poderós C; Rodrigo G; Peleato A; Polo J; Gutiérrez M
    Rev Esp Oncol; 1984; 31(3):477-82. PubMed ID: 6546176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Multivariate analysis of risk of cardiac complications in Hodgkin's lymphoma].
    Podol'skiĭ PN; Datsenko PV; Pan'shin GA; Sotnikov VM; Mel'nik IuD; Ivashin AV; Bozhenko VK
    Vopr Onkol; 2009; 55(4):447-50. PubMed ID: 19947368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute myocardial infarction after heart irradiation in young patients with Hodgkin's disease.
    Joensuu H
    Chest; 1989 Feb; 95(2):388-90. PubMed ID: 2914491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Silent myocardial infarction in a patient treated with radiation therapy and polychemotherapy for Hodgkin's lymphoma].
    Cordioli E; Tondini C; Pizzi C; Massarelli G
    Cardiologia; 1997 Jun; 42(6):635-8. PubMed ID: 9289380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin's disease patients.
    Zinzani PL; Gherlinzoni F; Piovaccari G; Frezza G; Bendandi M; Ferretti RM; Barbieri E; Fiacchini M; Babini L; Magnani B; Tura S
    Haematologica; 1996; 81(2):132-7. PubMed ID: 8641641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid diseases after treatment of Hodgkin's disease.
    Hancock SL; Cox RS; McDougall IR
    N Engl J Med; 1991 Aug; 325(9):599-605. PubMed ID: 1861693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity.
    Brusamolino E; Lunghi F; Orlandi E; Astori C; Passamonti F; Baraté C; Pagnucco G; Baio A; Franchini P; Lazzarino M; Bernasconi C
    Haematologica; 2000 Oct; 85(10):1032-9. PubMed ID: 11025593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger.
    Ng AK; Bernardo MP; Weller E; Backstrand KH; Silver B; Marcus KC; Tarbell NJ; Friedberg J; Canellos GP; Mauch PM
    J Clin Oncol; 2002 Apr; 20(8):2101-8. PubMed ID: 11956271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy.
    Hull MC; Morris CG; Pepine CJ; Mendenhall NP
    JAMA; 2003 Dec; 290(21):2831-7. PubMed ID: 14657067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.
    Engert A; Plütschow A; Eich HT; Lohri A; Dörken B; Borchmann P; Berger B; Greil R; Willborn KC; Wilhelm M; Debus J; Eble MJ; Sökler M; Ho A; Rank A; Ganser A; Trümper L; Bokemeyer C; Kirchner H; Schubert J; Král Z; Fuchs M; Müller-Hermelink HK; Müller RP; Diehl V
    N Engl J Med; 2010 Aug; 363(7):640-52. PubMed ID: 20818855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An affair of the heart.
    Boice JD
    J Natl Cancer Inst; 2007 Feb; 99(3):186-7. PubMed ID: 17284708
    [No Abstract]   [Full Text] [Related]  

  • 34. Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease.
    King V; Constine LS; Clark D; Schwartz RG; Muhs AG; Henzler M; Hutson A; Rubin P
    Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):881-9. PubMed ID: 8960517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
    Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma.
    Goodman KA; Riedel E; Serrano V; Gulati S; Moskowitz CH; Yahalom J
    J Clin Oncol; 2008 Nov; 26(32):5240-7. PubMed ID: 18809615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
    Chow LM; Nathan PC; Hodgson DC; Jenkin D; Weitzman S; Grant RM; Manson D; Bross A; Doyle JJ; Danjoux C; Greenberg ML
    J Clin Oncol; 2006 Dec; 24(36):5735-41. PubMed ID: 17179107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cardiac pathology in patients after therapy for Hodgkin's lymphoma].
    Danilenko AA; Shakhtarina SV
    Vopr Onkol; 2011; 57(1):119-25. PubMed ID: 21598720
    [No Abstract]   [Full Text] [Related]  

  • 39. Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease.
    Bossi G; Cerveri I; Volpini E; Corsico A; Baio A; Corbella F; Klersy C; Arico M
    Ann Oncol; 1997; 8 Suppl 1():19-24. PubMed ID: 9187424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.